Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Tejnaksh Healthcare Ltd Performance

Today's Low
22.75
arrowIcon
Today's High
23.78
52 Wk Low
22.55
arrowIcon
52 Wk High
39.00


Open

23.5

Traded Value (Cr)

4.05 L

Prev. Close

22.81

VWAP

23.02

Volume

17,784

Face Value

5

Tejnaksh Healthcare Ltd Fundamentals

Market Cap
₹ 47 Cr
P/E Ratio (TTM)
37.92
P/B Ratio
2.12
Debt to Equity
0.25
ROE
4.54 %
EPS (TTM)
0.62
Dividend Yield
0.00%
Book Value
11.09

Click here to know more about Fundamentals

Tejnaksh Healthcare Ltd Financials

Tejnaksh Healthcare Ltd Financials

Tejnaksh Healthcare Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 73.83 % 73.83 % 73.83 % 73.83 %
Retail 22.21 % 22.83 % 23.00 % 22.75 %
Others 3.68 % 2.75 % 2.58 % 2.84 %
FII 0.28 % 0.58 % 0.58 % 0.58 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

73.83%

Retail

22.21%

Others

3.68%

FII

0.28%

Mutual Funds

0.00%

Promoters

73.83%

Retail

22.83%

Others

2.75%

FII

0.58%

Mutual Funds

0.00%

Promoters

73.83%

Retail

23.00%

Others

2.58%

FII

0.58%

Mutual Funds

0.00%

Promoters

73.83%

Retail

22.75%

Others

2.84%

FII

0.58%

Mutual Funds

0.00%

Resistance and Support

₹24.26

PIVOT

resistance-arrow
Resistance
First Resistance₹24.520
Second Resistance₹24.890
Third Resistance₹25.150
support-arrow
Support
First Resistance₹23.890
Second Resistance₹23.630
Third Resistance₹23.260
RSI33.756
MACD-0.701
ADX7.481
CCI-206.187

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day38,98933,44485.78
Week16,34913,67684.60
1 Month16,32412,62684.24
6 Months000.00

About Tejnaksh Healthcare Ltd

Tejnaksh Healthcare Limited was incorporated in February 18, 2008. The Company is engaged in provision of hospital and healthcare and pharmacy services in Mumbai and other parts of Maharashtra. The Company has one subsidiary company, Tej Vedaant Healthcare Private Limited. In innovations, the Company has more than 150 research papers, 23 innovations, 13 patents applied, multiple national and international awards and to top it off, have multiple records in the Guinness Book, Limca Book, Asia & Ripley's Book. Today, the Company takes pride in manufacturing and distribution of many patented products. Being one of the leading innovative healthcare providing brands in the country, the Company continues to fathom newer avenues, break through newer achievements and reach newer heights. Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. The only healthcare IPO from the area and the speciality, the Company has been an ardent believer of high ethical and professional standards and focused on excellence in clinical services, diagnostic facilities and research. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Company's achievements were the multiple records that motivates the customers to improve treatment for Urology. The Company achieved the following milestones during the following years: In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , the Company established First Urology CME for the family physicians. In 2007, the Company set up 1st Laser Unit of North Maharashtra and 1st Flexible Ureteroscope of North Maharashtra. In 2008, the Company filed the 1st Innovation Patent. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination. In 2010, the Company was moved to the 1st Guinness World Record and established about 13 satellite centers. In 2011, the Company achieved the Records in Limca, Asia & Ripley's Book 2011 and Records in World Amazing Records, World Record Academy. In the same year, the company won the best research paper: Urological Society of India-WZ. In 2012, the Company won the S.S. Bapat prize for best innovation; it set up the First urology conference - Stonecon and hit the 2nd Guinness World Record. In 2013, the 5-PANG PCNL system became commercially available for the Company. The Company was won the S.S. Bapat Prize for Best Innovation during the year 2013. In 2014, the Company won the Second Guinness World Records. In the same year, the Company started first online opinion window for patients. In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic. It took the initiative to set up The International Health Tourism. In 2016, the Company set up the first indigenous PCNL simulation lab in the country. The PCNL simulators manufactured by Tejnaksh became commercially available during the year. The Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multi-speciality center in Navi Mumbai during the year.

Managing Director

Founded

2008

NSE Symbol

Tejnaksh Healthcare Ltd Management

NameDesignation
Ashish Vishwas RawandaleChairman / Executive Director
Preeti Ashish RawandaleNon-Exec & Non-Independent Dir
Kiran Madhavrao PawarIndependent Non Exe. Director
Vikramsinh Satish Khatal PatilIndependent Non Exe. Director
SANJAY BHIKAJIRAO KHATALNon-Exec & Non-Independent Dir
Suhas Vasantrao ThoratIndependent Non Exe. Director

Tejnaksh Healthcare Ltd News

Tejnaksh Healthcare consolidated net profit rises 74.19% in the December 2023 quarter
Sales rise 17.60% to Rs 3.14 crore
Tejnaksh Healthcare schedules board meeting
On 12 February 2024
Tejnaksh Healthcare consolidated net profit declines 30.95% in the September 2023 quarter
Sales decline 12.22% to Rs 3.09 crore
Tejnaksh Healthcare to announce Quarterly Result
On 11 November 2023
Tejnaksh Healthcare schedules AGM
On 21 September 2023
Tejnaksh Healthcare consolidated net profit declines 71.43% in the June 2023 quarter
Sales rise 5.21% to Rs 3.03 crore
Tejnaksh Healthcare to discuss results
On 12 August 2023
Tejnaksh Healthcare reports consolidated net loss of Rs 0.03 crore in the March 2023 quarter
Sales decline 9.86% to Rs 2.65 crore
Tejnaksh Healthcare to declare Quarterly Result
On 20 May 2023
Tejnaksh Healthcare consolidated net profit declines 54.41% in the December 2022 quarter
Sales decline 13.31% to Rs 2.67 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
APOLLOHOSP₹ 83,506 Cr
₹ 5,834.10
(0.45 %)
83.62
MAXHEALTH₹ 77,286 Cr
₹ 810.00
(1.86 %)
135.24
MEDANTA₹ 37,490 Cr
₹ 1,414.60
(1.31 %)
107.24
FORTIS₹ 34,097 Cr
₹ 441.15
(-2.32 %)
447.18
NH₹ 25,403 Cr
₹ 1,261.70
(1.50 %)
70.87

Tejnaksh Healthcare Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Tejnaksh Healthcare Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Tejnaksh Healthcare Ltd's share price is ₹22.75 as of May 10, 2024

Tejnaksh Healthcare Ltd's P/E ratio is 37.92 times as of May 10, 2024.

Tejnaksh Healthcare Ltd's most recent financial reports indicate a price-to-book ratio of 2.12, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Tejnaksh Healthcare Ltd's market is 48 Cr as on May 10, 2024.

The current financial records of Tejnaksh Healthcare Ltd show a 4.54% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Tejnaksh Healthcare Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Tejnaksh Healthcare Ltd's 52-week high and low as of May 10, 2024 are ₹23.78 and ₹22.75 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Tejnaksh Healthcare Ltd stands at 73.83%. During the same period, Institutional Investors have shown a slight decrease in their holdings, dropping from 0.58% to 0.28%.